Astec LifeSciences Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹19.87 billion
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Astec LifeSciences Limited had its IPO on under the ticker symbol 533138.
The company operates in the Other sector and Other industry. Astec LifeSciences Limited has a staff strength of 0 employees.
Shares of Astec LifeSciences Limited opened at ₹1431.45 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1368 - ₹1431.45, and closed at ₹1369.
This is a -3.74% slip from the previous day's closing price.
A total volume of 848 shares were traded at the close of the day’s session.
In the last one week, shares of Astec LifeSciences Limited have slipped by -2.87%.
Astec LifeSciences Limited's Key Ratios
Astec LifeSciences Limited has a market cap of ₹19.87 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Astec LifeSciences Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Astec LifeSciences Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Astec LifeSciences Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Astec LifeSciences Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Astec LifeSciences Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Astec LifeSciences Limited’s profitability.
Astec LifeSciences Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Astec LifeSciences Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹9.79 billion
- Total Liabilities
- ₹5.26 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Astec LifeSciences Limited ended 2023 with ₹9.79 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹9.79 billion while shareholder equity stood at ₹4.19 billion.
Astec LifeSciences Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹5.26 billion in other current liabilities, 196057000.00 in common stock, ₹4.00 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹4.73 million and cash and short-term investments were ₹27.54 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹108.63 million.
Astec LifeSciences Limited’s total current assets stands at ₹4.99 billion while long-term investments were ₹0 and short-term investments were ₹5.96 million. Its net receivables were ₹1.55 billion compared to accounts payable of ₹1.77 billion and inventory worth ₹2.95 billion.
In 2023, Astec LifeSciences Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Astec LifeSciences Limited paid ₹0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Astec LifeSciences Limited stock is currently trading at ₹1369 per share. It touched a 52-week high of ₹2283.0308 and a 52-week low of ₹2283.0308. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1329.77 and 200-day moving average was ₹1452.79 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Astec LifeSciences Limited
Similar Industry Stocks (Other)